Evergreen Private Wealth’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$265K Hold
1,055
0.1% 62
2026
Q1
$229K Buy
1,055
+111
+12% +$24.6K 0.09% 59
2025
Q4
$216K Sell
944
-55
-6% -$12.5K 0.09% 62
2025
Q3
$231K Sell
999
-38
-4% -$7.74K 0.09% 61
2025
Q2
$193K Sell
1,037
-215
-17% -$40K 0.08% 68
2025
Q1
$262K Buy
1,252
+1
+0.1% +$194 0.12% 59
2024
Q4
$222K Buy
1,251
+6
+0.5% +$1.1K 0.1% 63
2024
Q3
$246K Buy
1,245
+10
+0.8% +$1.87K 0.11% 64
2024
Q2
$212K Buy
1,235
+17
+1% +$2.82K 0.1% 67
2024
Q1
$222K Buy
1,218
+53
+5% +$9.13K 0.11% 69
2023
Q4
$181K Buy
+1,165
New +$170K 0.1% 69

Other funds holding ABBV

Evergreen Private Wealth's ABBV Position: Q2 2026 in Review

Evergreen Private Wealth held its AbbVie (ABBV) position steady in Q2 2026 at 1,055 shares worth $265K. The position accounts for 0.1% of the portfolio, ranked #62.

Evergreen Private Wealth first reported a position in ABBV in Q4 2023 and has held it in 11 quarters since. 4,209 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Evergreen Private Wealth held 1,055 shares of AbbVie worth $265K as of Q2 2026.
  • Evergreen Private Wealth left its AbbVie share count unchanged in Q2 2026.
  • AbbVie made up 0.1% of Evergreen Private Wealth's portfolio in Q2 2026, its #62 holding.
  • Evergreen Private Wealth first reported a position in AbbVie in Q4 2023 and has held it in 11 quarters since.
  • 4,209 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Evergreen Private Wealth's 13F filing for Q2 2026, filed 23 Jul 2026.